# FDA Inspection 1197383 - GPT Pharmaceuticals Private Ltd - January 27, 2023

Source: https://www.globalkeysolutions.net/records/fda_inspections/gpt-pharmaceuticals-private-ltd/4a16ac2f-6bd2-49fc-a5a0-75af75f7b63c
Source feed: FDA_Inspections

> FDA Inspection 1197383 for GPT Pharmaceuticals Private Ltd on January 27, 2023. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1197383
- Company Name: GPT Pharmaceuticals Private Ltd
- Inspection Date: 2023-01-27
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1096441 - 2019-06-28](https://www.globalkeysolutions.net/records/fda_inspections/gpt-pharmaceuticals-private-ltd/61b2c8d9-f06f-48b9-aa0d-82556bf8ca4d)
- [FDA Inspection 989445 - 2016-07-29](https://www.globalkeysolutions.net/records/fda_inspections/gpt-pharmaceuticals-private-ltd/4f6e21fa-4218-477a-85d1-6845ed67959c)

Company: https://www.globalkeysolutions.net/companies/gpt-pharmaceuticals-private-ltd/e809d1f5-7f6f-4a11-99d7-ce89f08e1cf3

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c